LMRI vs RDNT
LMRI: Lumexa is a leading national provider of outpatient diagnostic imaging services and radiologist interpretation with 188 imaging centers across 13 states, generating revenue from patient imaging, radiologist services, and management fees. RDNT: Leading operator of multi-modality diagnostic imaging centers across the US, with integrated AI-powered radiology software and digital health solutions.
Side-by-side fundamentals
| Metric | LMRI | RDNT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $10.65 | $59.22 | |
| Market cap as of 2026-07-23 | $1.1B | $4.8B | |
| Net margin as of 2026-07-23 | -3.6% | -0.7% | RDNT higher |
| Gross margin as of 2026-07-23 | +15.1% | +24.1% | RDNT higher |
| Operating margin as of 2026-07-23 | +8.1% | +2.9% | LMRI higher |
| ROE as of 2026-07-23 | -8.0% | -1.4% | RDNT higher |
| ROA as of 2026-07-23 | -2.7% | -0.4% | RDNT higher |
| Debt / equity as of 2026-07-23 | 1.47 | 1.01 | RDNT lower |
| Revenue growth (YoY) as of 2026-07-23 | +8.0% | +14.7% | RDNT higher |
| Revenue CAGR (3y) SEC XBRL | n/a | +12.6% | |
| Beta as of 2026-07-23 | 1.01 | 1.41 | |
| 1-year return as of 2026-07-22 close | -39.8% | +3.6% | RDNT higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.